gefitinib,tepotinib,pembrolizumab
astrazeneca,immutep,merck
['ease,(-please),(-disease),(-incrrease),(-decrease)', 'insight,(-insights)', 'immutep']
immutep ltd ( $imm $imm.ax ) has released " insight-003 triple combination data presented at sitc 2022 " on 11/11/2022 at 8:16 am aest #unitedstates